| MX2020008582 (A) |
MX20200008582 |
20190304 |
PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING HETEROTOPIC OSSIFICATION. |
UNIV SAITAMA MEDICAL [JP] |
| WO2022244829 (A1) |
WO2022JP20756 |
20220519 |
BIOMETRIC INFORMATION MANAGEMENT SYSTEM, BIOMETRIC INFORMATION MANAGEMENT METHOD, AND BIOMETRIC INFORMATION MANAGEMENT PROGRAM |
UNIV SAITAMA MEDICAL [JP] |
| WO2022185742 (A1) |
WO2022JP01353 |
20220117 |
PROPHYLACTIC OR THERAPEUTIC COMPOSITION FOR DISSEMINATED INTRAVASCULAR COAGULATION SYNDROME |
UNIV SAITAMA MEDICAL [JP] |
| US2022267453 (A1) |
US202017629715 |
20200722 |
ANTIBODY RECOGNIZING EXTRACELLULAR REGION OF ALK2/ACVR1 |
UNIV SAITAMA MEDICAL [JP]; DAIICHI SANKYO CO LTD [JP] |
| US2022270245 (A1) |
US202017629570 |
20200722 |
ESTIMATOR LEARNING DEVICE, ESTIMATOR LEARNING METHOD, AND ESTIMATOR LEARNING PROGRAM |
UNIV SAITAMA MEDICAL [JP]; UNIV KYUSHU NAT UNIV CORP [JP] |
| JP2022117411 (A) |
JP20210162653 |
20211001 |
RODENT HAVING RODENT-MUTANT ALK2 GENE |
UNIV SAITAMA MEDICAL |
| WO2022168971 (A1) |
WO2022JP04638 |
20220207 |
METHOD FOR CONTROLLING IMPLANTATION RATE IN MAMMAL, AGENT FOR INCREASING IMPLANTATION RATE IN MAMMAL, AND MEDICINE |
UNIV SAITAMA MEDICAL [JP] |
| JP2022105066 (A) |
JP20220070115 |
20220421 |
IMMUNOLOGICAL BIOMARKER FOR PREDICTING CLINICAL EFFECT OF CANCER IMMUNOTHERAPY |
UNIV SAITAMA MEDICAL |
| US2022223239 (A1) |
US202017609865 |
20200507 |
DETERMINATION DEVICE, DETERMINATION METHOD, AND DETERMINATION PROGRAM |
UNIV SAITAMA MEDICAL [JP] |
| WO2022138767 (A1) |
WO2021JP47703 |
20211222 |
ANALYSIS SYSTEM, ANALYSIS METHOD, ANALYTIC DATA ACQUISITION DEVICE, AND ANALYTIC PROGRAM |
UNIV SAITAMA MEDICAL [JP] |
| WO2022131198 (A1) |
WO2021JP45772 |
20211213 |
COMBINATION DRUG FOR TREATING KIDNEY CANCER AND THERAPEUTIC EFFECT ENHANCER FOR TYROSINE KINASE INHIBITOR |
UNIV SAITAMA MEDICAL [JP] |
| WO2022080327 (A1) |
WO2021JP37615 |
20211011 |
ESTIMATOR LEARNING DEVICE, ESTIMATOR LEARNING METHOD, AND ESTIMATOR LEARNING PROGRAM |
UNIV SAITAMA MEDICAL [JP] |
| JP2022055095 (A) |
JP20200162474 |
20200928 |
STENT AND STENT DELIVERY SYSTEM |
UMIDAS INC; UNIV SAITAMA MEDICAL |
| US2022107324 (A1) |
US202017432744 |
20200219 |
PERIPHERAL BLOOD BIOMARKER FOR EVALUATING ANTI-TUMOR IMMUNE EFFECT OF RADIATION THERAPY |
UNIV SAITAMA MEDICAL [JP] |
| US2022096552 (A1) |
US202017432819 |
20200219 |
METHOD AND COMPOSITION FOR PREDICTING LONG-TERM SURVIVAL IN CANCER IMMUNOTHERAPY |
UNIV SAITAMA MEDICAL [JP] |
| WO2022054796 (A1) |
WO2021JP32852 |
20210907 |
BIOMARKER FOR PREDICTING RESPONSE TO CANCER TREATMENT |
UNIV SAITAMA MEDICAL [JP] |
| WO2022050230 (A1) |
WO2021JP31777 |
20210830 |
COMPOSITION INHIBITING ACTIVATION OF ADENOSINE RECEPTOR |
UNIV SAITAMA MEDICAL [JP] |
| US2022073988 (A1) |
US201917299141 |
20191205 |
METHOD FOR PREDICTING EFFICACY OF RHEUMATOID ARTHRITIS THERAPEUTIC AGENT AND BIOMARKER USED THEREIN |
DNA CHIP RESEARCH INC [JP]; UNIV KEIO [JP]; UNIV SAITAMA MEDICAL [JP] |
| WO2022044788 (A1) |
WO2021JP29473 |
20210810 |
DOUBLE-STRANDED NUCLEIC ACID MOLECULE, DNA, VECTOR, FEMALE CANCER CELL GROWTH INHIBITION AGENT, FEMALE CANCER TUMOR FORMATION INHIBITION AGENT, PHARMACEUTICAL, AND USE OF LONG-CHAIN NONCODING RNA |
UNIV SAITAMA MEDICAL [JP] |
| JP2022017865 (A) |
JP20200120675 |
20200714 |
CYTOTOXIC T CELL EPITOPE PEPTIDE OF SARS-COV-2 AND UTILIZATION THEREOF |
UNIV SAITAMA MEDICAL |
| US11447554 (B2); US2022041738 (A1) |
US202117511357 |
20211026 |
ANTI-ALK2 ANTIBODY |
UNIV SAITAMA MEDICAL [JP]; DAIICHI SANKYO CO LTD [JP] |
| WO2021260966 (A1) |
WO2020JP43886 |
20201125 |
COMPOSITION TARGETING ADENOSINE-PRODUCING ENZYME |
UNIV SAITAMA MEDICAL [JP] |
| JP2021188970 (A) |
JP20200092609 |
20200527 |
METHOD FOR EXAMINING LUNG CANCER BASED ON ANALYSIS OF PROTEIN COMPOSITE BODY IN EXTRACELLULAR VESICLE |
UNIV SAITAMA MEDICAL |
| JP2021181909 (A) |
JP20200086891 |
20200518 |
DIFFERENCE DETECTION CONJUGATE COMPENSATION CARS MEASUREMENT APPARATUS |
ATA CO LTD; UNIV SAITAMA MEDICAL |
| JP2021078705 (A) |
JP20190208388 |
20191119 |
MUSCLE RELAXATION MONITOR |
UNIV SAITAMA MEDICAL; ADTEX KK |
| WO2021084791 (A1) |
WO2020JP24876 |
20200624 |
COMPOSITION TARGETED TO ADENOSINE A2A RECEPTOR |
IMMNO INC [JP]; UNIV SAITAMA MEDICAL [JP] |
| JP2021048812 (A) |
JP20190175273 |
20190926 |
PRIMER SETS FOR DETECTING PRESENCE OR ABSENCE OF MUTATION IN BASE SEQUENCE ENCODING 83RD AMINO ACID OF GONOCOCCAL DNA GYRASE SUBUNIT A, PRIMER SETS FOR EVALUATING PRESENCE OR ABSENCE OF GONOCOCCAL SENSITIVITY TO FLUOROQUINOLONE AND USES THEREOF |
UNIV SAITAMA MEDICAL; NAT INSTITUTE OF INFECTIOUS DISEASES; UNIV NIHON |
| JP2021020862 (A) |
JP20190136589 |
20190725 |
PEPTIDE, CELL MIGRATION INHIBITOR, CELLULAR INFILTRATION INHIBITOR, CANCER CELL METASTASIS INHIBITOR, AND MEDICINE |
UNIV SAITAMA MEDICAL |
| JP2020198279 (A) |
JP20190105473 |
20190605 |
SECONDARY BATTERY REFRESH EFFECT PREDICTION SYSTEM, SECONDARY BATTERY REFRESH EFFECT PREDICTION DEVICE, SECONDARY BATTERY REFRESH EFFECT PREDICTION METHOD, AND PROGRAM |
UNIV SAITAMA MEDICAL; SHIN EI ELECTRONIC MEASURING CO LTD |
| JP2020187534 (A) |
JP20190091417 |
20190514 |
RADIO WAVE INTENSITY MONITORING SYSTEM |
TAISEI CORP; UNIV SAITAMA MEDICAL |
| BRPI1009855 (A2) |
BR2010PI09855 |
20100312 |
METHOD FOR DETERMINING SENSITIVITY TO IRINOTECAN AND USE THEREOF |
YAKULT HONSHA KK [JP]; UNIV SAITAMA MEDICAL [JP] |
| JP2020144012 (A) |
JP20190041046 |
20190306 |
STAINED IMAGE ESTIMATOR LEARNING DEVICE, IMAGE PROCESSING DEVICE, STAINED IMAGE ESTIMATOR LEARNING METHOD, IMAGE PROCESSING METHOD, STAINED IMAGE ESTIMATOR LEARNING PROGRAM, AND IMAGE PROCESSING PROGRAM |
UNIV SAITAMA MEDICAL; TOKYO INST TECH |
| WO2020137076 (A1) |
WO2019JP39415 |
20191004 |
METHOD FOR PREDICTING SUSCEPTIBILITY OF CANCER TO PARP INHIBITORS, AND METHOD FOR DETECTING CANCER HAVING HOMOLOGOUS RECOMBINATION REPAIR DEFICIENCY |
UNIV TOKYO [JP]; UNIV SAITAMA MEDICAL [JP] |
| JP2020093987 (A) |
JP20180231377 |
20181211 |
NEW COMPOUND WITH BONE METABOLISM INHIBITORY ACTIVITY AND MANUFACTURING METHOD THEREOF |
KITASATO INST; UNIV SAITAMA MEDICAL |
| JP2020081448 (A); JP7179288 (B2) |
JP20180221329 |
20181127 |
CATHETER OPERATION SUPPORT DEVICE AND METHOD, PROGRAM AND X-RAY MEDICAL SYSTEM |
R TECH KK; UNIV TOHOKU; UNIV SAITAMA MEDICAL; KOKURITSU IYAKUHIN SHOKUHIN EISEI KENKYUSHO; KOBE CITY HOSPITAL ORGANIZATION |
| US10835551 (B2); US2020121710 (A1) |
US202016732725 |
20200102 |
DOUBLE-STRANDED NUCLEIC ACID MOLECULE, DNA, VECTOR, CANCER CELL GROWTH INHIBITOR, CANCER CELL MIGRATION INHIBITOR, AND DRUG |
UNIV SAITAMA MEDICAL [JP] |
| JP2020048426 (A) |
JP20180177931 |
20180921 |
SCREENING AGENTS, SCREENING KITS, AND SCREENING METHODS FOR SCREENING AT LEAST ONE AGENT SELECTED FROM THE GROUP CONSISTING OF AGENTS FOR INCREASING OR REDUCING THE NUMBER OF CELLS OF FRIZZLED 3 EXPRESSING CELLS, DIABETES PREVENTION OR TREATMENT AGENTS, INSULINOMA PREVENTION OR TREATMENT AGENTS, AND INSULIN SECRETION PROMOTERS OR INHIBITORS |
UNIV SAITAMA MEDICAL |
| JP2020027052 (A); JP7191361 (B2) |
JP20180152478 |
20180813 |
METHOD FOR AIDING DETERMINATION OF AFFECTION POSSIBILITY OF GYNECOLOGY DISEASE, METHOD FOR COLLECTING DATA TO DIAGNOSE AFFECTION POSSIBILITY OF GYNECOLOGY DISEASE, AND DIAGNOSTIC KIT OF GYNECOLOGY DISEASE |
UNIV SAITAMA MEDICAL |
| JP2019198271 (A); JP7097606 (B2) |
JP20180094774 |
20180516 |
USE OF DOUBLE-STRANDED NUCLEIC ACID MOLECULES, DNA, VECTORS, CANCER CELL GROWTH INHIBITORS, MEDICINES, AND SPON1-TRIM29 FUSION GENES |
UNIV SAITAMA MEDICAL |
| JP2019190883 (A); JP7106810 (B2) |
JP20180080878 |
20180419 |
NEW LUNG CANCER MARKER |
UNIV SAITAMA MEDICAL |
| JP2019156807 (A); JP7064203 (B2) |
JP20180049308 |
20180316 |
ANTIHUMAN CD26 MONOCLONAL ANTIBODY |
JUNTENDO; UNIV SAITAMA MEDICAL |
| JP2019149987 (A) |
JP20180038978 |
20180305 |
METHOD FOR PREDICTING THE EFFECTIVENESS OF RADIOTHERAPY TO HEAD AND NECK SQUAMOUS CELL CARCINOMA |
UNIV SAITAMA MEDICAL |
| WO2019172213 (A1) |
WO2019JP08494 |
20190305 |
NANOPARTICLE, NANOPARTICLE PRODUCTION METHOD, AND ANTI-TUMOR AGENT |
NAT UNIV CORP YOKOHAMA NAT UNIV [JP]; UNIV SAITAMA MEDICAL [JP]; NAT INST INF & COMM TECH [JP]; UNIV OSAKA [JP] |
| JP2019131505 (A) |
JP20180014419 |
20180131 |
ANTI-CANCER AGENT |
UNIV KANAZAWA; UNIV SAITAMA MEDICAL |
| US2019189260 (A1) |
US201716324959 |
20170808 |
METHOD OF EVALUATING THERAPEUTIC EFFECT OF DRUG IN CANCER PATIENT, METHOD OF GENERATING EVALUATION DATA OF THERAPEUTIC EFFECT, THERAPEUTIC EFFECT EVALUATION DEVICE, AND THERAPEUTIC EFFECT EVALUATION PROGRAM |
UNIV SAITAMA MEDICAL [JP]; HAMAMATSU PHOTONICS KK [JP] |
| AR110928 (A1) |
AR2018P100290 |
20180207 |
BIOMARCADOR INMUNOLÓGICO PARA PREDECIR EL EFECTO CLÍNICO DE INMUNOTERAPIA DEL CÁNCER |
UNIV SAITAMA MEDICAL [JP] |
| US10809200 (B2); US2019137402 (A1) |
US201716309732 |
20170616 |
TEST OBJECT VISUALIZING DEVICE |
UNIV SAITAMA MEDICAL [JP] |
| JP2019045540 (A); JP6901072 (B2) |
JP20170165001 |
20170830 |
IMAGE PROCESSING DEVICE, IMAGE PROCESSING METHOD, AND IMAGE PROCESSING PROGRAM |
UNIV SAITAMA MEDICAL |
| JP2019174432 (A); JP6454950 (B1) |
JP20180077994 |
20180329 |
SIMPLE MEASURING METHOD AND MEASURING DEVICE FOR OXIDIZABLE VLDL (VLDL SUSCEPTIBILITY TO OXIDATION) AND OXIDIZABLE LDL (LDL SUSCEPTIBILITY TO OXIDATION) THAT ARE JUDGED TO HAVE HIGH RISK OF MYOCARDIAL INFARCTION AND CEREBRAL INFARCTION DUE TO ATHEROSCLEROSIS |
ASKA SPECIAL LABORATORY CO LTD; UNIV SAITAMA MEDICAL; NAT CEREBRAL & CARDIOVASCULAR CT |
| CN109182376 (A); CN109182376 (B) |
CN201811123541 |
20131029 |
Method of manufacturing differentiated pluripotent stem cell |
UNIV SAITAMA MEDICAL |
| WO2018221562 (A1) |
WO2018JP20696 |
20180530 |
COMPOSITION FOR INHIBITING PRODUCTION OF IL-8 FROM ACTIVATED T CELL |
IMMNO INC [JP]; UNIV SAITAMA MEDICAL [JP] |
| JP2018175579 (A); JP6497531 (B2) |
JP20170082048 |
20170418 |
ANKLE HEMODYNAMICS INDEX CALCULATION DEVICE, ANKLE HEMODYNAMICS INDEX CALCULATION METHOD, ANKLE HEMODYNAMICS INDEX CALCULATION PROGRAM, AND BLOOD PRESSURE MEASURING DEVICE |
UNIV SAITAMA MEDICAL |
| US11499140 (B2); US2018312812 (A1) |
US201615770910 |
20161028 |
Method for Producing Pancreatic Endocrine Cells, and Transdifferentiation Agent |
UNIV SAITAMA MEDICAL [JP] |
| JP2018124913 (A); JP6879752 (B2) |
JP20170018649 |
20170203 |
MEDICAL DEVICE MONITORING SYSTEM |
HITACHI SYSTEMS LTD; UNIV SAITAMA MEDICAL |
| US10370730 (B2); US2018163278 (A1) |
US201415103184 |
20141211 |
DETECTION METHOD FOR MUTATION IN 93RD AMINO ACID OF HEPATITIS C VIRUS NS5A PROTEIN, AND DETECTION KIT FOR MUTATION IN 93RD AMINO ACID OF HEPATITIS C VIRUS NS5A PROTEIN |
UNIV SAITAMA MEDICAL |
| JP2018067203 (A) |
JP20160206293 |
20161020 |
DANGER NOTIFICATION DEVICE, DANGER NOTIFICATION METHOD, AND CALIBRATION METHOD FOR DANGER NOTIFICATION DEVICE |
UNIV SAITAMA MEDICAL |
| JP2018008915 (A); JP6727051 (B2) |
JP20160140818 |
20160715 |
THICKENING AGENT, COMPOSITION KIT, AND METHOD FOR THICKENING COMPOSITION |
UNIV SAITAMA MEDICAL; KURINIKO KK; MORINAGA MILK INDUSTRY CO LTD |
| JP2017217037 (A) |
JP20160111350 |
20160602 |
APPLICATOR FOR UTERINE CANCER INTRACAVITARY IRRADIATION, RADIATION TREATMENT PLANNING METHOD OF UTERINE CANCER AND RADIATION TREATMENT PLANNING DEVICE OF UTERINE CANCER |
UNIV SAITAMA MEDICAL; UNIV GUNMA |
| JP2017203816 (A); JP6714258 (B2) |
JP20160094053 |
20160509 |
OPTICAL PARAMETRIC OSCILLATOR |
ATA CO LTD; UNIV SAITAMA MEDICAL |
| JP2017203646 (A); JP6606803 (B2) |
JP20160094042 |
20160509 |
FREQUENCY MODULATION CARS MEASUREMENT DEVICE |
ATA CO LTD; UNIV SAITAMA MEDICAL |
| US10669613 (B2); US2017327928 (A1) |
US201715668107 |
20170803 |
TITANIUM ALLOY |
NIPPON PISTON RING CO LTD [JP]; NATIONAL UNIV CORPORATION SAITAMA UNIV [JP] |
| CN106983859 (A) |
CN20161141668 |
20161122 |
A preparing method of an immunity inducer |
SYSMEX CORP; HIROSHI HANDA; UNIV SAITAMA MEDICAL |
| US10214728 (B2); US2017211046 (A1) |
US201515323576 |
20150703 |
PANCREATIC ENDOCRINE CELLS, METHOD FOR PRODUCING SAME, AND TRANSDIFFERENTIATION AGENT |
UNIV SAITAMA MEDICAL [JP] |
| JP2017119691 (A); JP6927483 (B2) |
JP20160250667 |
20161226 |
NOVEL COMPOUND HAVING BONE METABOLISM INHIBITORY ACTIVITY AND METHOD FOR PRODUCING THE SAME |
KITASATO INST; UNIV SAITAMA MEDICAL |
| JP2017114835 (A); JP6715004 (B2) |
JP20150255012 |
20151225 |
IMMUNOSTIMULANT AND PRODUCTION METHOD THEREFOR |
HANDA HIROSHI; UNIV SAITAMA MEDICAL; SYSMEX CORP |
| JP2017109965 (A); JP6778365 (B2) |
JP20150246912 |
20151218 |
ANTI-PANCREATIC POLYPEPTIDE MONOCLONAL ANTIBODY |
JUNTENDO; UNIV SAITAMA MEDICAL |
| JP2017079730 (A); JP6985691 (B2) |
JP20160207898 |
20161024 |
METHODS FOR PREDICTING THERAPEUTIC EFFECTS OF BIOLOGICAL PREPARATION FOR RHEUMATOID ARTHRITIS, AND METHODS FOR SELECTING OPTIMAL DRUG USING THE SAME |
DNA CHIP RESEARCH INC; KEIO GIJUKU; UNIV SAITAMA MEDICAL |
| JP2016198203 (A); JP6484091 (B2) |
JP20150079160 |
20150408 |
EXAMINATION METHOD OF STOP POSITION IN APPLICATOR OF GUIDE WIRE TIP SMALL LINE SOURCE AND EXAMINATION TOOL |
UNIV SAITAMA MEDICAL; AARUTEKKU KK |
| US2016311875 (A1); US9856304 (B2) |
US201414893730 |
20140523 |
NEW PEPTIDE AND APPLICATION THEREOF |
UNIV SAITAMA MEDICAL [JP] |
| JP2016134437 (A); JP6742690 (B2) |
JP20150006924 |
20150116 |
FIBER RING LASER, OPTICAL PULSE AND OPTICAL TOMOGRAPHIC IMAGING DEVICE |
UNIV SAITAMA MEDICAL |
| JP2016131705 (A); JP5946927 (B1) |
JP20150007759 |
20150119 |
SURGICAL SPECIMEN RECOVERY FORCEPS AND SURGICAL SPECIMEN RECOVERY BAG |
UNIV SAITAMA MEDICAL |
| JP2016121097 (A); JP6432114 (B2) |
JP20140261988 |
20141225 |
DRUGS FOR INDUCING IMMUNE RESPONSE |
IMUNO:KK; UNIV SAITAMA MEDICAL |
| WO2016098873 (A1) |
WO2015JP85435 |
20151218 |
METHOD FOR DETERMINING RISK OF DEVELOPING PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA, AND COMPOSITION FOR TREATING PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA |
UNIV TOKYO [JP]; UNIV SAITAMA MEDICAL [JP]; KYORIN UNIVERSITY [JP] |
| JP2016077574 (A) |
JP20140212372 |
20141017 |
IDENTIFICATION MARKER AND MEDICAL SUPPORT SYSTEM BY AUGMENTED REALITY TECHNOLOGY USING THE SAME |
UNIV SAITAMA MEDICAL |
| JP2016070798 (A) |
JP20140200824 |
20140930 |
METHOD FOR ASSISTING DETERMINATION OF BEHCET'S DISEASE AND METHOD FOR ASSISTING EVALUATION OF ACTIVITY OF BEHCET'S DISEASE |
UNIV SAITAMA MEDICAL |
| JP2016045996 (A); JP6353739 (B2) |
JP20140167252 |
20140820 |
ELECTRIC CONDUCTION UNIT, SLOPE STATE DETECTION DEVICE AND SLOPE STATE DETECTION METHOD |
UNIV SAITAMA MEDICAL; YAMAKEI:KK |
| WO2016047509 (A1) |
WO2015JP76214 |
20150916 |
PEPTIDE-BOUND LIPOSOME, CYTOTOXIC T LYMPHOCYTE ACTIVATOR, AND ANTITUMOR VACCINE |
UNIV SAITAMA MEDICAL [JP] |
| JP2016037473 (A); JP6370634 (B2) |
JP20140162011 |
20140808 |
MALE STERILITY PREVENTIVE/THERAPEUTIC AGENT, AND FOOD/FEED |
UNIV SAITAMA MEDICAL |
| US2016002734 (A1); US9873920 (B2) |
US201414771465 |
20140227 |
METHOD FOR EVALUATING SIDE-EFFECT ONSET RISK IN ANTICANCER DRUG TREATMENT, INCLUDING DETECTING MUC4 GENE POLYMORPHISM |
UNIV SAITAMA MEDICAL [JP] |
| JP2015154718 (A) |
JP20140030106 |
20140219 |
COLONY-COUNTING APPARATUS, COLONY-COUNTING METHOD, AND COLONY-COUNTING PROGRAM |
UNIV SAITAMA MEDICAL |
| US10413559 (B2); US2015352132 (A1) |
US201414763618 |
20140128 |
THERAPEUTIC AGENT FOR DEMYELINATING DISEASE |
OCHANOMIZU UNIVERSITY [JP]; UNIV SAITAMA MEDICAL [JP] |
| US2015343089 (A1); US9814785 (B2) |
US201514831539 |
20150820 |
HEPATITIS C VIRUS LIPOSOME VACCINE |
UNIV SAITAMA MEDICAL [JP]; JAPAN AS REPRESENTED BY THE DIRECTOR GENERAL OF NAT INST OF INFECTIOUS DISEASES [JP]; NOF CORP [JP] |
| JP2015141282 (A); JP6255257 (B2) |
JP20140013438 |
20140128 |
MEASURING DEVICE AND MEASURING METHOD |
UNIV SAITAMA MEDICAL |
| JP2015139398 (A) |
JP20140013666 |
20140128 |
APPARATUS AND METHOD FOR NUCLEIC ACID EXTRACTION |
LIFETECH CO LTD; UNIV SAITAMA MEDICAL |
| WO2015115221 (A1) |
WO2015JP51194 |
20150119 |
MEASURING DEVICE AND MEASURING METHOD |
UNIV SAITAMA MEDICAL [JP] |
| US10213319 (B2); US2015157468 (A1) |
US201314410437 |
20130810 |
NAVIGATION DEVICE FOR JOINT REPLACEMENT AND SURGICAL SUPPORT DEVICE |
ARTHRODESIGN LTD [JP]; LEXI CO LTD [JP]; UNIV SAITAMA MEDICAL [JP] |
| US2015140661 (A1) |
US201314403026 |
20130524 |
METHOD FOR PRODUCING PANCREATIC HORMONE-PRODUCING CELL, PANCREATIC HORMONE-PRODUCING CELL, AND DIFFERENTIATION/INDUCTION PROMOTER |
UNIV SAITAMA MEDICAL [JP] |
| JP2015084939 (A); JP5969447 (B2) |
JP20130225850 |
20131030 |
ANALYZER OF ERROR BETWEEN RADIATION IRRADIATION FIELD AND LIGHT IRRADIATION FIELD IN RADIOTHERAPY APPARATUS |
UNIV SAITAMA MEDICAL; AARUTEKKU KK |
| US2015045244 (A1) |
US201114358517 |
20111117 |
METHOD FOR DETERMINING RHEUMATOID ARTHRITIS ACTIVITY INDICATOR, AND BIOMARKER USED THEREIN |
TAKEUCHI TSUTOMU [JP]; AMANO KOICHI [JP]; ISHIZAWA YOHEI [JP]; NAKAMURA SEIJI [JP]; TANINO MOTOHIKO [JP]; HATA YUKO [JP]; DNA CHIP RESEARCH INC [JP]; UNIV SAITAMA MEDICAL [JP]; UNIV KEIO [JP] |
| JP2015002713 (A); JP6210752 (B2) |
JP20130130358 |
20130621 |
PRODUCTION METHOD OF NON-HUMAN MODEL ANIMAL WITH ENHANCED PHOSPHORYLATION OF TAU PROTEIN |
UNIV SAITAMA MEDICAL |
| US2015005641 (A1); US9521953 (B2) |
US201314381021 |
20130226 |
MEASUREMENT DEVICE AND MEASUREMENT METHOD |
UNIV SAITAMA MEDICAL [JP] |
| US2015002934 (A1); US9612449 (B2) |
US201314377288 |
20130207 |
AXIALLY SYMMETRIC POLARIZATION CONVERSION ELEMENT |
UNIV SAITAMA MEDICAL [JP]; UNIV UTSUNOMIYA [JP] |
| WO2014192927 (A1) |
WO2014JP64452 |
20140530 |
COMPUTER SIMULATION SYSTEM |
UNIV KYOTO [JP]; UNIV SAITAMA MEDICAL [JP] |
| JP2014217345 (A) |
JP20130100312 |
20130510 |
COMPOSITION FOR PRODUCING INDUCED PLURIPOTENT STEM CELL, AND METHOD FOR PRODUCING INDUCED PLURIPOTENT STEM CELL |
UNIV SAITAMA MEDICAL |
| JP2014217344 (A) |
JP20130100311 |
20130510 |
COMPOSITION FOR PRODUCING INDUCED PLURIPOTENT STEM CELL, AND METHOD FOR PRODUCING INDUCED PLURIPOTENT STEM CELL |
UNIV SAITAMA MEDICAL |
| JP2014217339 (A); JP6321921 (B2) |
JP20130099962 |
20130510 |
ANTI-TLS MONOCLONAL ANTIBODY AND METHOD FOR PRODUCING THE SAME, HYBRIDOMA AND METHOD FOR PRODUCING THE SAME, AND ANTI-TLS MONOCLONAL ANTIBODY-CONTAINING COMPOSITION |
UNIV SAITAMA MEDICAL |
| US2014350073 (A1); US9284557 (B2) |
US201414324803 |
20140707 |
DOUBLE-STRANDED NUCLEIC ACID MOLECULE, CANCER CELL PROLIFERATION INHIBITOR AND PHARMACEUTICAL AGENT SUITABLE FOR PREVENTION OR TREATMENT OF CANCER |
UNIV SAITAMA MEDICAL [JP]; RNAI CO LTD [JP] |
| WO2014181682 (A1) |
WO2014JP61378 |
20140423 |
COMPOSITION FOR MANUFACTURING INDUCED PLURIPOTENT STEM CELL AND METHOD FOR MANUFACTURING INDUCED PLURIPOTENT STEM CELL |
UNIV SAITAMA MEDICAL [JP] |
| WO2014148529 (A1) |
WO2014JP57471 |
20140319 |
DOUBLE-STRANDED NUCLEIC ACID MOLECULE, DNA, VECTOR, CANCER CELL PROLIFERATION INHIBITOR, AND PHARMACEUTICAL PRODUCT |
UNIV SAITAMA MEDICAL [JP] |
| JP2014153343 (A); JP5930984 (B2) |
JP20130026271 |
20130214 |
SHAPE MEASUREMENT DEVICE |
UNIV SAITAMA MEDICAL |
| US2014286978 (A1) |
US201214117575 |
20120424 |
CYTOTOXIC T LYMPHOCYTE INDUCER |
TOKYO INST TECH [JP]; LSIP LLC [JP]; UNIV SAITAMA MEDICAL [JP]; LSIP LLC [JP] |
| WO2014042167 (A1) |
WO2013JP74452 |
20130911 |
MONOCLONAL ANTIBODY AGAINST EBAG9, HYBRIDOMA, AND APPLICATION FOR MONOCLONAL ANTIBODY AGAINST EBAG9 |
UNIV SAITAMA MEDICAL [JP] |
| JP2014212374 (A); JP5396559 (B1) |
JP20130086355 |
20130417 |
IMAGE ENCODING DEVICE, IMAGE ENCODING METHOD, IMAGE ENCODING PROGRAM, AND RECORDING MEDIUM |
UNIV SAITAMA MEDICAL |
| JP2014005205 (A) |
JP20100231918 |
20101014 |
EBOLA VIRUS LIPOSOME VACCINE |
UNIV SAITAMA MEDICAL; NAT INST INFECTIOUS DISEASES; NOF CORP |
| US2014030742 (A1); US9458210 (B2) |
US201214008677 |
20120402 |
ANTIBODY REACTING WITH NATIVE COCHLIN-TOMOPROTEIN (CTP) AND METHOD FOR MEASURING CTP USING SAME |
IKEZONO TETSUO [JP]; SHIKAZE SATOMI [JP]; UNIV SAITAMA MEDICAL [JP] |
| JP2013255488 (A) |
JP20130102114 |
20130514 |
NON-HUMAN ANIMAL MODEL OF DIASTOLIC HEART FAILURE, METHOD FOR PRODUCING THE SAME, AND METHOD FOR SCREENING SUBSTANCE HAVING DIASTOLIC HEART FAILURE PREVENTING OR SYMPTOM IMPROVING ACTIVITY |
UNIV SAITAMA MEDICAL |
| JP2013234981 (A); JP6019288 (B2) |
JP20120116943 |
20120507 |
METHOD OF SIMPLY CLASSIFYING OR DETERMINING PHENOTYPE OF DYSLIPIDEMIA OR HYPERLIPEMIA |
ASKA SPECIAL LAB CO LTD; UNIV SAITAMA MEDICAL |
| WO2013183702 (A1) |
WO2013JP65679 |
20130606 |
HELPER-DEPENDENT ADENOVIRUS VECTOR, METHOD FOR VISUALIZING MATURE OSTEOBLASTS, AND METHOD FOR PRODUCING MATURE OSTEOBLASTS |
UNIV SAITAMA MEDICAL [JP] |
| JP2013225257 (A) |
JP20120098038 |
20120423 |
UNSAFE ACTION DETECTION SYSTEM AND UNSAFE ACTION DETECTION METHOD |
SEIKO EPSON CORP; UNIV SAITAMA MEDICAL |
| JP2013220148 (A) |
JP20120092373 |
20120413 |
UNSAFE BEHAVIOR DETECTION DEVICE AND UNSAFE BEHAVIOR DETECTION METHOD |
SEIKO EPSON CORP; UNIV SAITAMA MEDICAL |
| JP2013205411 (A); JP5953897 (B2) |
JP20120091395 |
20120328 |
METHOD FOR DETERMINING PARTICLE DIAMETER OF LIPOPROTEIN AND PARTICLE MARKER OF LIPOPROTEIN |
ASKA SPECIAL LAB CO LTD; UNIV SAITAMA MEDICAL |
| US2013252241 (A1) |
US201313872631 |
20130429 |
METHOD OF DISTINGUISHING INFLAMMATORY PATHOGEN CAUSING ACUTE RESPIRATORY INFECTION |
UNIV SAITAMA MEDICAL [JP] |
| JP2013126422 (A); JP5721150 (B2) |
JP20130052314 |
20130314 |
METHOD FOR PREDICTING ONSET RISK OF AGE-RELATED MACULAR DEGENERATION |
UNIV SAITAMA MEDICAL |
| DK2168589 (T3) |
DK20070791094T |
20070720 |
INSULIN SECRETION INDUCER, AND ACCELERATOR FOR INCREASING THE NUMBER OF PANCREATIC ß-CELLS |
UNIV SAITAMA MEDICAL [JP] |
| JP2013081430 (A); JP6024939 (B2) |
JP20110224666 |
20111012 |
METHOD OF MEASURING DRUG-METABOLIZING FUNCTION |
UNIV KANAZAWA; UNIV SAITAMA MEDICAL |
| JP2013053850 (A) |
JP20100002301 |
20100107 |
CIRCULARLY POLARIZED LIGHT CONVERSION DEVICE |
UNIV SAITAMA MEDICAL |
| US2013011921 (A1) |
US201113578777 |
20110215 |
METHOD FOR PRODUCTION OF ARTIFICIAL PLURIPOTENT STEM CELL |
UNIV SAITAMA MEDICAL [JP]; HISHIDA TOMOAKI [JP]; OKUDA AKIHIKO [JP]; KATO HIDEMASA [JP] |
| WO2012147757 (A1) |
WO2012JP61016 |
20120425 |
METHOD AND KIT FOR DETERMINING AGE-RELATED MACULAR DEGENERATION VULNERABILITY |
UNIV SAITAMA MEDICAL [JP]; SANTEN PHARMA CO LTD [JP]; INOUE SATOSHI [JP]; INOUE KUNIKO [JP]; MORI KEISUKE [JP]; YONEYA SHIN [JP]; KOHDA MASAKAZU [JP]; OKAZAKI YASUSHI [JP] |
| US2012214183 (A1); US8993254 (B2) |
US201013504413 |
20101026 |
METHODS FOR EVALUATING RISK OF MOTHER'S MILK OR FOOD INDUCING AN ONSET OF ATOPIC DERMATITIS, AND MOTHER'S MILK OR FOOD WITH REDUCED RISK OF INDUCING AN ONSET OF ATOPIC DERMATITIS |
MATSUSHITA SHO [JP]; HIGASHI TAKEHIRO [JP]; UNIV SAITAMA MEDICAL [JP]; IMMNO INC [JP] |
| JP2012105555 (A); JP5725469 (B2) |
JP20100255134 |
20101115 |
BONE DIFFERENTIATION INHIBITOR AND METHOD FOR PRODUCING THE SAME |
KITASATO INST; UNIV SAITAMA MEDICAL |
| WO2012074085 (A1) |
WO2011JP77890 |
20111202 |
MARKER FOR DETERMINATION OF SENSITIVITY TO TRIPLET COMBINATION ANTI-CANCER AGENT |
UNIV SAITAMA MEDICAL [JP]; YAKULT HONSHA KK [JP]; NISHIYAMA MASAHIKO [JP]; EGUCHI HIDETAKA [JP]; WADA SATORU [JP] |
| JP2012021951 (A) |
JP20100162031 |
20100716 |
SOFT X-RAY MICROSCOPE |
UNIV SAITAMA MEDICAL |
| CN102232083 (A); CN102232083 (B) |
CN200980147542 |
20091127 |
Avian influenza vaccine |
JAPAN AS REPRESENTED BY THE DI; UNIV HOKKAIDO NAT UNIV CORP; UNIV SAITAMA MEDICAL; NOF CORP |
| US2011262529 (A1); US8828929 (B2) |
US200913131560 |
20091127 |
CYTOTOXIC T CELL EPITOPE PEPTIDE FOR SARS CORONAVIRUS, AND USE THEREOF |
NOF CORP [JP]; JP NAT INST OF INFECTIOUS DISEASES [JP]; UNIV SAITAMA MEDICAL [JP] |
| WO2011126050 (A1) |
WO2011JP58724 |
20110406 |
POLYMER MOLDED BODY FOR PULLING BIOLOGICAL TISSUE, MEDICAL PULLING MEMBER USING SAME, AND MEDICAL PULLING TOOL |
HITACHI CHEMICAL CO LTD [JP]; UNIV SAITAMA MEDICAL [JP]; KOBAYASHI KAZUTOSHI [JP]; SUTO KUNIHIRO [JP]; NISHIMURA MAKOTO [JP]; KITA HIROTO [JP] |
| JP2011135838 (A); JP5706612 (B2) |
JP20090298772 |
20091228 |
MARKER, METHOD AND KIT FOR JUDGING LIABILITY TO AGE-RELATED MACULAR DEGENERATION |
UNIV SAITAMA MEDICAL; SANTEN PHARMA CO LTD |
| WO2011087009 (A1) |
WO2011JP50331 |
20110112 |
REGULATORY GENE CONTROLLING SACCHAROMETABOLISM, LIPID METABOLISM, OBESITY AND LIFE, PROTEIN, AND SCREENING METHOD |
UNIV SAITAMA MEDICAL [JP]; INOUE SATOSHI [JP]; IKEDA KAZUHIRO [JP] |
| JP2011126853 (A) |
JP20090289848 |
20091221 |
AVIAN INFLUENZA VACCINE |
NAT INST OF INFECTIOUS DISEASES; UNIV HOKKAIDO; UNIV SAITAMA MEDICAL; NOF CORP |
| JP2010263818 (A) |
JP20090116845 |
20090513 |
NEW PPARgamma PROMOTER SEQUENCE AND APPLICATION THEREOF |
UNIV SAITAMA MEDICAL; NAT INST OF ADVANCED IND SCIEN |
| JP2010233498 (A) |
JP20090085128 |
20090331 |
Th21 CELL CLONE AND PRODUCTION AND USE OF THE SAME |
IMUNO KK; UNIV SAITAMA MEDICAL |
| JP2010230565 (A); JP5308208 (B2) |
JP20090079895 |
20090327 |
APPARATUS AND METHOD FOR MEASUREMENT OF POLARIZATION CHARACTERISTICS |
UNIV SAITAMA MEDICAL; UNIV TOKYO AGRICULTURE |
| JP2010213585 (A) |
JP20090061208 |
20090313 |
OSTEOBLAST DIFFERENTIATION MARKER, OSTEOGENESIS PROMOTER, AND OSTEOGENESIS INHIBITOR |
UNIV SAITAMA MEDICAL |
| JP2010210410 (A) |
JP20090056756 |
20090310 |
THREE-DIMENSIONAL SHAPE MEASURING DEVICE |
UNIV SAITAMA MEDICAL |
| JP2010172307 (A) |
JP20090020915 |
20090130 |
METHOD AND APPARATUS FOR PREDICTING PHARMACOLOGICAL EFFICACY OF SOLUBLE TNFalpha/LTalpha RECEPTOR PREPARATION ON RHEUMATOID ARTHRITIS |
UNIV SAITAMA MEDICAL |
| US2010173405 (A1); US8124754 (B2) |
US20090642979 |
20091221 |
Double-Stranded Nucleic Acid Molecule Cancer Cell Proliferation Inhibitor and Pharmaceutical Agent Suitable for Prevention or Treatment of Uterine Cancer, Breast Cancer, and Bladder Cancer |
UNIV SAITAMA MEDICAL [JP]; RNAI CO LTD [JP] |
| JP2010111581 (A) |
JP20070014786 |
20070125 |
MEDICINE CONTAINING DOPAMINE D2-LIKE RECEPTOR AGONIST AS ACTIVE INGREDIENT AND SCREENING METHOD |
IMUNO KK; UNIV SAITAMA MEDICAL |
| JP2010094062 (A) |
JP20080266721 |
20081015 |
MEDIUM, CULTURE METHOD AND DIFFERENTIATION METHOD FOR MAINTAINING PLURIPOTENCY OF MESENCHYMAL STEM CELL |
UNIV SAITAMA MEDICAL |
| JP2010064957 (A) |
JP20080229880 |
20080908 |
AGENT FOR PREVENTING OR TREATING DISEASE RELATED TO KLOTHO AND FGF23, CONTAINING CALCIMIMETIC AS ACTIVE INGREDIENT |
UNIV SAITAMA MEDICAL; KYOWA HAKKO KIRIN CO LTD |
| JP2010030956 (A) |
JP20080195099 |
20080729 |
PROMOTER AND INHIBITOR OF OSTEOBLAST CELL DIFFERENTIATION, OSTEOGENESIS PROMOTER, OSTEOPOROSIS DRUG, ANTI-OBESITY AGENT, AND SCREENING METHOD |
UNIV SAITAMA MEDICAL |
| JP2010024198 (A) |
JP20080189427 |
20080723 |
PHARMACEUTICAL FOR TREATING AND PREVENTING TYPE 1 DIABETES COMPRISING DOPAMINE D2-LIKE RECEPTOR AGONIST AS EFFECTIVE COMPONENT, AND SCREENING METHOD |
IMUNO KK; UNIV SAITAMA MEDICAL |
| JP2010004794 (A) |
JP20080167267 |
20080626 |
EVALUATION METHOD OF TH17 ADJUVANT ACTIVITY AND INHIBITION OF ACTIVITY BY USING EXPRESSION OF HUMAN JAGGED1 GENE AS INDEX, AND SCREENING METHOD OF SUBSTANCE HAVING TH17 ADJUVANT ACTIVITY AND SUBSTANCE INHIBITING ACTIVITY |
IMUNO KK; UNIV SAITAMA MEDICAL |
| US2009155782 (A1) |
US20060988812 |
20060707 |
Homoeologous Region Determining Method by Homo Junction Fingerprint Method, Homoeologous Region Determining Device, and Gene Screening Method |
TOMY DIGITAL BIOLOGY CO LTD [JP]; UNIV SAITAMA MEDICAL [JP] |
| JP2009073745 (A) |
JP20070242895 |
20070919 |
PROPHYLACTIC/THERAPEUTIC AGENT FOR MENSTRUATION-RELATED MIGRAINE, MENSTRUAL PAIN AND MENOPAUSAL DISORDER |
UNIV SAITAMA MEDICAL |
| JP2009073744 (A) |
JP20070242730 |
20070919 |
PROPHYLACTIC/THERAPEUTIC AGENT FOR MIGRAINE |
UNIV SAITAMA MEDICAL |
| JP2009050232 (A) |
JP20070222082 |
20070829 |
METHOD FOR DIAGNOSING COLLAGEN DISEASE |
UNIV SAITAMA MEDICAL |
| JP2009027972 (A); JP5226256 (B2) |
JP20070194922 |
20070726 |
METHOD FOR PREDICTING ONSET RISK OF AGE-RELATED MACULAR DEGENERATION |
NIPRO CORP; UNIV SAITAMA MEDICAL |
| JP2009011184 (A); JP5180526 (B2) |
JP20070173768 |
20070702 |
CLONE OF Th17 CELL AND PRODUCTION AND USE OF THE SAME |
IMUNO KK; UNIV SAITAMA MEDICAL |
| JP2008306974 (A) |
JP20070157402 |
20070614 |
METHOD FOR DETERMINING(HEPATITIS C VIRUS) GENOTYPE, AND LNA(LOCKED NUCLEIC ACID) PROBE AND KIT EACH USED FOR THE METHOD |
UNIV SAITAMA MEDICAL |
| JP2008297220 (A) |
JP20070142412 |
20070529 |
PREVENTING AND TREATING AGENT OF BONE DISORDER ACCOMPANIED BY BONE FRACTURE AND REDUCTION OF BONE MASS |
METABOLOME PHARMACEUTICALS INC; UNIV SAITAMA MEDICAL |
| JP2008260710 (A) |
JP20070104032 |
20070411 |
ANTICANCER AGENT AND METHOD FOR DETERMINING ORAL DOSE THEREOF |
UNIV SAITAMA MEDICAL |